Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis

We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical microbiology 2015-05, Vol.53 (5), p.1719-1721
Hauptverfasser: Filisetti, Denis, Yera, Hélène, Villard, Odile, Escande, Benoît, Wafo, Estelle, Houfflin-Debarge, Véronique, Delhaes, Laurence, Bastien, Patrick
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1721
container_issue 5
container_start_page 1719
container_title Journal of clinical microbiology
container_volume 53
creator Filisetti, Denis
Yera, Hélène
Villard, Odile
Escande, Benoît
Wafo, Estelle
Houfflin-Debarge, Véronique
Delhaes, Laurence
Bastien, Patrick
description We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network on CT classification system and case definitions. Neonatal amniotic fluid testing had an overall sensitivity of 54% (95% confidence interval [95% CI], 39 to 69%) and a specificity of 100% (95% CI, 99 to 100%). Its sensitivity was 33% (95% CI, 13 to 59%) when antenatal diagnosis was positive and 68% (95% CI, 48 to 84%) when antenatal diagnosis was negative or lacking. This difference in sensitivity may have been due to treatment of antenatally diagnosed cases. Relative to postnatal serology, neonatal amniotic fluid testing allowed an earlier diagnosis to be made in 26% of the cases (95% CI, 9 to 51%).
doi_str_mv 10.1128/JCM.02358-14
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4400781</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1687667852</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-950b7a2604efba744be398f8d80846d7cb0a219603d3eb0632d44d0fc8ecfea23</originalsourceid><addsrcrecordid>eNqNkU1P3DAQhq0KVBbaW89VjlRqYMaxHeeChFYtH1rUSytxsxzHWVwl9jZ2EPx7EpYi4MRppJln3vl4CfmCcIRI5fHl8uoIaMFljuwDWSBUMhcCrnfIAqDiOWJR7pH9GP8CIGOcfyR7lIuKcSoX5HoZfBpcPSYXfBbazNvgddJdpnvvQnIma7vRNVmyMTm_zlLIGqfXPkQXZ94Ev7bezR0p3IVNp2M_1z6R3VZ30X5-igfkz88fv5fn-erX2cXydJUbxjHlFYe61FQAs22tS8ZqW1SylY0EyURTmho0xUpA0RS2BlHQhrEGWiOtaa2mxQE52epuxrq3jbHTObpTm8H1erhXQTv1uuLdjVqHW8UYQClxEvi2Fbh503Z-ulJzDihSBF7dzuzh07Ah_Bunj6jeRWO7Tk9vG6NCIUshSsnpO9CSUUAOMKHft6gZQoyDbZ_XQFCzx2ryWD16rJBN-NeXFz_D_00tHgCa3qM_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1674201500</pqid></control><display><type>article</type><title>Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis</title><source>American Society for Microbiology</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Filisetti, Denis ; Yera, Hélène ; Villard, Odile ; Escande, Benoît ; Wafo, Estelle ; Houfflin-Debarge, Véronique ; Delhaes, Laurence ; Bastien, Patrick</creator><contributor>Gilligan, P. H.</contributor><creatorcontrib>Filisetti, Denis ; Yera, Hélène ; Villard, Odile ; Escande, Benoît ; Wafo, Estelle ; Houfflin-Debarge, Véronique ; Delhaes, Laurence ; Bastien, Patrick ; Gilligan, P. H.</creatorcontrib><description>We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network on CT classification system and case definitions. Neonatal amniotic fluid testing had an overall sensitivity of 54% (95% confidence interval [95% CI], 39 to 69%) and a specificity of 100% (95% CI, 99 to 100%). Its sensitivity was 33% (95% CI, 13 to 59%) when antenatal diagnosis was positive and 68% (95% CI, 48 to 84%) when antenatal diagnosis was negative or lacking. This difference in sensitivity may have been due to treatment of antenatally diagnosed cases. Relative to postnatal serology, neonatal amniotic fluid testing allowed an earlier diagnosis to be made in 26% of the cases (95% CI, 9 to 51%).</description><identifier>ISSN: 0095-1137</identifier><identifier>EISSN: 1098-660X</identifier><identifier>DOI: 10.1128/JCM.02358-14</identifier><identifier>PMID: 25694528</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>Amniotic Fluid - parasitology ; Female ; Humans ; Infant, Newborn ; Life Sciences ; Microbiology and Parasitology ; Molecular Diagnostic Techniques - methods ; Parasitology ; Polymerase Chain Reaction - methods ; Pregnancy ; Sensitivity and Specificity ; Time Factors ; Toxoplasmosis, Congenital - diagnosis ; Toxoplasmosis, Congenital - parasitology</subject><ispartof>Journal of clinical microbiology, 2015-05, Vol.53 (5), p.1719-1721</ispartof><rights>Copyright © 2015, American Society for Microbiology. All Rights Reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2015, American Society for Microbiology. All Rights Reserved. 2015 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-950b7a2604efba744be398f8d80846d7cb0a219603d3eb0632d44d0fc8ecfea23</citedby><cites>FETCH-LOGICAL-c451t-950b7a2604efba744be398f8d80846d7cb0a219603d3eb0632d44d0fc8ecfea23</cites><orcidid>0000-0002-0525-0012</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400781/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4400781/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,3186,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25694528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.umontpellier.fr/hal-02121059$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Gilligan, P. H.</contributor><creatorcontrib>Filisetti, Denis</creatorcontrib><creatorcontrib>Yera, Hélène</creatorcontrib><creatorcontrib>Villard, Odile</creatorcontrib><creatorcontrib>Escande, Benoît</creatorcontrib><creatorcontrib>Wafo, Estelle</creatorcontrib><creatorcontrib>Houfflin-Debarge, Véronique</creatorcontrib><creatorcontrib>Delhaes, Laurence</creatorcontrib><creatorcontrib>Bastien, Patrick</creatorcontrib><title>Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis</title><title>Journal of clinical microbiology</title><addtitle>J Clin Microbiol</addtitle><description>We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network on CT classification system and case definitions. Neonatal amniotic fluid testing had an overall sensitivity of 54% (95% confidence interval [95% CI], 39 to 69%) and a specificity of 100% (95% CI, 99 to 100%). Its sensitivity was 33% (95% CI, 13 to 59%) when antenatal diagnosis was positive and 68% (95% CI, 48 to 84%) when antenatal diagnosis was negative or lacking. This difference in sensitivity may have been due to treatment of antenatally diagnosed cases. Relative to postnatal serology, neonatal amniotic fluid testing allowed an earlier diagnosis to be made in 26% of the cases (95% CI, 9 to 51%).</description><subject>Amniotic Fluid - parasitology</subject><subject>Female</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Life Sciences</subject><subject>Microbiology and Parasitology</subject><subject>Molecular Diagnostic Techniques - methods</subject><subject>Parasitology</subject><subject>Polymerase Chain Reaction - methods</subject><subject>Pregnancy</subject><subject>Sensitivity and Specificity</subject><subject>Time Factors</subject><subject>Toxoplasmosis, Congenital - diagnosis</subject><subject>Toxoplasmosis, Congenital - parasitology</subject><issn>0095-1137</issn><issn>1098-660X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkU1P3DAQhq0KVBbaW89VjlRqYMaxHeeChFYtH1rUSytxsxzHWVwl9jZ2EPx7EpYi4MRppJln3vl4CfmCcIRI5fHl8uoIaMFljuwDWSBUMhcCrnfIAqDiOWJR7pH9GP8CIGOcfyR7lIuKcSoX5HoZfBpcPSYXfBbazNvgddJdpnvvQnIma7vRNVmyMTm_zlLIGqfXPkQXZ94Ev7bezR0p3IVNp2M_1z6R3VZ30X5-igfkz88fv5fn-erX2cXydJUbxjHlFYe61FQAs22tS8ZqW1SylY0EyURTmho0xUpA0RS2BlHQhrEGWiOtaa2mxQE52epuxrq3jbHTObpTm8H1erhXQTv1uuLdjVqHW8UYQClxEvi2Fbh503Z-ulJzDihSBF7dzuzh07Ah_Bunj6jeRWO7Tk9vG6NCIUshSsnpO9CSUUAOMKHft6gZQoyDbZ_XQFCzx2ryWD16rJBN-NeXFz_D_00tHgCa3qM_</recordid><startdate>20150501</startdate><enddate>20150501</enddate><creator>Filisetti, Denis</creator><creator>Yera, Hélène</creator><creator>Villard, Odile</creator><creator>Escande, Benoît</creator><creator>Wafo, Estelle</creator><creator>Houfflin-Debarge, Véronique</creator><creator>Delhaes, Laurence</creator><creator>Bastien, Patrick</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>M7N</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-0525-0012</orcidid></search><sort><creationdate>20150501</creationdate><title>Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis</title><author>Filisetti, Denis ; Yera, Hélène ; Villard, Odile ; Escande, Benoît ; Wafo, Estelle ; Houfflin-Debarge, Véronique ; Delhaes, Laurence ; Bastien, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-950b7a2604efba744be398f8d80846d7cb0a219603d3eb0632d44d0fc8ecfea23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Amniotic Fluid - parasitology</topic><topic>Female</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Life Sciences</topic><topic>Microbiology and Parasitology</topic><topic>Molecular Diagnostic Techniques - methods</topic><topic>Parasitology</topic><topic>Polymerase Chain Reaction - methods</topic><topic>Pregnancy</topic><topic>Sensitivity and Specificity</topic><topic>Time Factors</topic><topic>Toxoplasmosis, Congenital - diagnosis</topic><topic>Toxoplasmosis, Congenital - parasitology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Filisetti, Denis</creatorcontrib><creatorcontrib>Yera, Hélène</creatorcontrib><creatorcontrib>Villard, Odile</creatorcontrib><creatorcontrib>Escande, Benoît</creatorcontrib><creatorcontrib>Wafo, Estelle</creatorcontrib><creatorcontrib>Houfflin-Debarge, Véronique</creatorcontrib><creatorcontrib>Delhaes, Laurence</creatorcontrib><creatorcontrib>Bastien, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Filisetti, Denis</au><au>Yera, Hélène</au><au>Villard, Odile</au><au>Escande, Benoît</au><au>Wafo, Estelle</au><au>Houfflin-Debarge, Véronique</au><au>Delhaes, Laurence</au><au>Bastien, Patrick</au><au>Gilligan, P. H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis</atitle><jtitle>Journal of clinical microbiology</jtitle><addtitle>J Clin Microbiol</addtitle><date>2015-05-01</date><risdate>2015</risdate><volume>53</volume><issue>5</issue><spage>1719</spage><epage>1721</epage><pages>1719-1721</pages><issn>0095-1137</issn><eissn>1098-660X</eissn><abstract>We evaluated the molecular diagnosis of congenital toxoplasmosis (CT) on neonatal amniotic fluid samples from 488 mother-child pairs. Maternal infection during pregnancy was diagnosed and dated or could not be ruled out. Forty-six cases of CT were defined according to the European Research Network on CT classification system and case definitions. Neonatal amniotic fluid testing had an overall sensitivity of 54% (95% confidence interval [95% CI], 39 to 69%) and a specificity of 100% (95% CI, 99 to 100%). Its sensitivity was 33% (95% CI, 13 to 59%) when antenatal diagnosis was positive and 68% (95% CI, 48 to 84%) when antenatal diagnosis was negative or lacking. This difference in sensitivity may have been due to treatment of antenatally diagnosed cases. Relative to postnatal serology, neonatal amniotic fluid testing allowed an earlier diagnosis to be made in 26% of the cases (95% CI, 9 to 51%).</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>25694528</pmid><doi>10.1128/JCM.02358-14</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-0525-0012</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0095-1137
ispartof Journal of clinical microbiology, 2015-05, Vol.53 (5), p.1719-1721
issn 0095-1137
1098-660X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4400781
source American Society for Microbiology; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Amniotic Fluid - parasitology
Female
Humans
Infant, Newborn
Life Sciences
Microbiology and Parasitology
Molecular Diagnostic Techniques - methods
Parasitology
Polymerase Chain Reaction - methods
Pregnancy
Sensitivity and Specificity
Time Factors
Toxoplasmosis, Congenital - diagnosis
Toxoplasmosis, Congenital - parasitology
title Contribution of neonatal amniotic fluid testing to diagnosis of congenital toxoplasmosis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T23%3A47%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Contribution%20of%20neonatal%20amniotic%20fluid%20testing%20to%20diagnosis%20of%20congenital%20toxoplasmosis&rft.jtitle=Journal%20of%20clinical%20microbiology&rft.au=Filisetti,%20Denis&rft.date=2015-05-01&rft.volume=53&rft.issue=5&rft.spage=1719&rft.epage=1721&rft.pages=1719-1721&rft.issn=0095-1137&rft.eissn=1098-660X&rft_id=info:doi/10.1128/JCM.02358-14&rft_dat=%3Cproquest_pubme%3E1687667852%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1674201500&rft_id=info:pmid/25694528&rfr_iscdi=true